My ePortfolio Register   

What is the biology behind immunotherapy for MM?

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.03.17
Views: 1604

Dr Alexander Lesokhin - Memorial Sloan Kettering Cancer Center, New York, USA

Dr Lesokhin speaks with ecancer at the 16th International Myeloma Workshop about the biology behind immunotherapy in MM and its implications for the future.

Immunotherapy for myeloma is also discussed by Dr Zonder, here.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence